OBIO® Capital Access Advisory Program (CAAP)
Receive up to $250,000 in Potential Funding.
The Ontario Bioscience Innovation Organization (OBIO) is an Ontario not-for-profit membership-based organization that strives to help further the commercialization of Ontario’s human health science. The Capital Access Advisory Program (CAAP) operates downstream from existing entrepreneurship programs and focuses on accelerating technology commercialization, working towards Series A financing and strategic partnerships.
Attention: This program is currently closed. You can speak with a member of our team about future intake periods or similar funding programs you may be eligible for, get email updates through our weekly newsletter, or look through our list of available funding programs in our directory page.
Demande de Financement
Donnez à votre demande les meilleures chances d’être approuvée. Ryan a un taux d’approbation de 86 % pour tous les programmes de financement canadiens.
OBIO® Capital Access Advisory Program
Amount of Funding
Your company’s pitch to investors at the OBIO Investment Summit will determine the amount of funding your company receives from the Capital Access Advisory Program.
OBIO® Capital Access Advisory Program
Eligible Applicants
- A private, promising health science company in Ontario;
- Developing human health products in therapeutics, medical devices, diagnostics, or digital health tech;
- Has closed or is about to close a “seed” investment within six months;
- Intent on raising series A financing in 2022 to 2023;
- Has enough resources and funding runway to reach next key value inflection points to allow for their Series A raise; and
- Is a company that would benefit substantially from coaching/participating in CAAP to advance their business strategy and raise capital.
OBIO® Capital Access Advisory Program
Company Benefits
- Receive guidance from international Steering Committee of investors, healthcare executives, and business experts on strategy for a successful raise;
- Access to a network of advisors with expertise in technology commercialization, business development, fundraising and negotiations; and
- Investor readiness, targeting and introductions.
OBIO® Capital Access Advisory Program
Program Deadline
The deadline for applications is September 16th, 2022.
Demande de Financement
Nous permettons à nos clients de gagner en moyenne 95 % de temps par rapport aux entreprises qui font leur propre demande de financement.
Ontario Bioscience Innovation Organization (OBIO) News
No posts